Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Profit After Tax Growth (3y) (2012 - 2026)

Analysis

Vertex Pharmaceuticals (VRTX) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 0.97%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 21.28%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 39.29%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 12.02%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 11.28%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 19.87%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -129.22%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -28.18%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 6.30%
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn 17.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.30%
Mar 31, 2026 13.80%
Dec 31, 2025 13.30%
Sep 30, 2025 5.19%
Jun 30, 2025 8.42%
Mar 31, 2025 -5.35%
Dec 31, 2024 5.84%
Sep 30, 2024 7.06%
Jun 30, 2024 -281.76%
Mar 31, 2024 18.96%
Dec 31, 2023 17.05%
Sep 30, 2023 15.76%
Jun 30, 2023 3.03%
Mar 31, 2023 5.10%
Dec 31, 2022 11.98%
Sep 30, 2022 152.91%
Jun 30, 2022 44.72%
Mar 31, 2022 41.56%
Dec 31, 2021 -20.81%
Sep 30, 2021 87.74%
API Access

Vertex Pharmaceuticals Profit After Tax Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax-growth-3y&ticker=VRTX&period=max&api_key=YOUR_API_KEY